Cargando…
Current Immunological and Clinical Perspective on Vaccinations in Multiple Sclerosis Patients: Are They Safe after All?
Vaccines work by stimulating the immune system, and their immunogenicity is key in achieving protection against specific pathogens. Questions have been raised whether in Multiple Sclerosis (MS) patients they could induce disease exacerbation and whether vaccines could possibly act as a trigger in th...
Autores principales: | Witman Tsur, Shani, Adrian Zaher, Eli, Tsur, Meydan, Kania, Karolina, Kalinowska-Łyszczarz, Alicja |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8068297/ https://www.ncbi.nlm.nih.gov/pubmed/33917860 http://dx.doi.org/10.3390/ijms22083859 |
Ejemplares similares
-
The impact of disease modifying therapies on cognitive functions typically impaired in multiple sclerosis patients: a clinician’s review
por: Kania, Karolina, et al.
Publicado: (2023) -
The Immunology of Neuromyelitis Optica—Current Knowledge, Clinical Implications, Controversies and Future Perspectives
por: Jasiak-Zatonska, Michalina, et al.
Publicado: (2016) -
The Role of Neurotrophins in Multiple Sclerosis—Pathological and Clinical Implications
por: Kalinowska-Lyszczarz, Alicja, et al.
Publicado: (2012) -
Case Report: Baló's Concentric Sclerosis-Like Lesion in a Patient With Relapsing-Remitting Multiple Sclerosis Treated With Dimethyl Fumarate
por: Kania, Karolina, et al.
Publicado: (2022) -
The cross-reactivity of binding antibodies with different interferon beta formulations used as disease-modifying drugs in multiple sclerosis patients
por: Wencel-Warot, Agnieszka, et al.
Publicado: (2016)